FMS
Fresenius Medical Care AG
23.48
13 x 23.43
7 x 23.44
bid
ask
+
0.63
2.73%
10:12 AM
timesize
| Ytd | -1.41% | |
| 1y | -17.07% |
23.24
day range
23.51
20.02
52 week range
28.21
| Open | 23.39 | Prev Close | 22.86 | Low | 23.24 | High | 23.51 | Mkt Cap | 12.63B |
| Vol | 160.50K | Avg Vol | 747.70K | EPS | 1.86 | P/E | 12.64 | Forward P/E | 5.88 |
| Beta | 0.81 | Short Ratio | 3.63 | Inst. Own | 9.74% | Dividend | 0.87 | Div Yield | 3.84 |
| Ex Div Date | 05-22 | Earning | 08-04 | 50-d Avg | 22.30 | 200-d Avg | 23.57 | 1yr Est | 25.48 |
| Income Statement | |||
| Total Revenue | 4.61B | ||
| Revenues (USD) | 5.30B | ||
| Cost of Revenue | 3.43B | ||
| Gross Profit | 1.18B | ||
| Operating Expenses | 934.62M | ||
| Research and Development Expense | 38.31M | ||
| Selling, General and Administrative Expense | 748.94M | ||
| Operating Income | 244.87M | ||
| Interest Expense | 93.30M | ||
| Income Tax Expense | 42.75M | ||
| Net Income | 117.53M | ||
| Net Income Common Stock | 117.53M | ||
| Net Income Common Stock (USD) | 135.09M | ||
| Consolidated Income | 164.76M | ||
| Net Income to Non-Controlling Interests | 47.23M | ||
| Earnings per Basic Share | 0.22 | ||
| Earnings per Basic Share (USD) | 0.25 | ||
| Earnings per Diluted Share | 0.22 | ||
| Earning Before Interest & Taxes (EBIT) | 253.58M | ||
| Earning Before Interest & Taxes (USD) | 291.47M | ||
| Weighted Average Shares | 279.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.24B | ||
| Cash and Equivalents (USD) | 1.42B | ||
| Investments | 1.09B | ||
| Investments Current | 384.20M | ||
| Investments Non-Current | 701.40M | ||
| Trade and Non-Trade Receivables | 3.61B | ||
| Current Assets | 8.11B | ||
| Property, Plant & Equipment Net | 6.44B | ||
| Total Assets | 31.47B | ||
| Debt Current | 4.24B | ||
| Total Debt | 13.05B | ||
| Current Liabilities | 6.73B | ||
| Debt Non-Current | 8.81B | ||
| Total Liabilities | 17.26B | ||
| Accumulated Retained Earnings (Deficit) | 12.30B | ||
| Accumulated Other Comprehensive Income | -1.44B | ||
| Shareholders Equity | 13.24B | ||
| Shareholders Equity (USD) | 15.22B | ||
| Assets Non-Current | 23.36B | ||
| Total Debt (USD) | 15.00B | ||
| Goodwill and Intangible Assets | 15.10B | ||
| Inventory | 2.30B | ||
| Liabilities Non-Current | 10.53B | ||
| Trade and Non-Trade Payables | 890.43M | ||
| Tax Assets | 449.28M | ||
| Tax Liabilities | 967.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 462.94M | ||
| Net Cash Flow from Financing | -436.09M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -359.97M | ||
| Capital Expenditure | -186.99M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.13M | ||
| Issuance (Purchase) of Equity Shares | -347.33M | ||
| Issuance (Repayment) of Debt Securities | -16.30M | ||
| Net Cash Flow from Investing | -169.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 20.64M | ||
| Net Cash Flow from Operations | 226.89M | ||
| Effect of Exchange Rate Changes on Cash | 18.71M | ||